How to get the most of out of your UAT process and focus your efforts where they should be.
The special requirements that must be met as the cloud as adopted by life sciences organizations.
How to be sure that the solution you’ve chosen is best suited to completing this task with speed and ease.
What can be done to that the technology opening new doors in the capture and analysis of clinical data, and the guidance responsible for regulating them, keep up with one another?
Learn how clinical development technologies and advanced analytics navigate sponsors through the challenges of patient scarcity to transform precision oncology research.
The reasons behind the physician monitors’ reluctance, and what technology needs to offer to convince monitors their work can be more efficient — quickly detecting safety signals and speeding time to submission.
Although there are clear benefits with the first pill to include a digital sensor that tracks if and when it has been ingested brings, there are also questions regarding patient privacy and choice.
In this paper, some of our thought-leaders provide their insights on what they are watching for and what they anticipate in 2018 in clinical trial technology, regulatory changes, and scientific developments.
Takeaways from MAGI 2017 West regarding changes taking place in the industry at large and an analysis of what’s driving those changes.
Explore the impact of the high cost of clinical trials and how the industry can mitigate it.
|
|
|
|
|
|
|
|
|